A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine

Get answers to your Colon Cancer Surgery questions.
Colorectal cancer
Colon and rectal cancers can be detected early using the screening tests discussed below. These tests can find precancerous polyps and colorectal cancers at stages early enough for complete removal and cure.
American Cancer Society Recommendations. The American Cancer Society, the American College of Radiology, and the U.S. Multi-Society Task Force on Colorectal Cancer have released joint consensus guidelines for colorectal cancer screening.
These organizations recommend the following test options and schedules for adults age 50 years and older with no significant risk factors for colorectal cancer. Discuss with your doctor which test is most appropriate for you.
For stool tests, the American Cancer Society recommends the following options. Stool tests must be repeated at regular intervals and a colonoscopy must be performed if stool test results are abnormal.
Stool tests include:
U.S. Preventive Services Task Force Recommendations. The U.S. Preventive Services Task Force (USPSTF) has slightly different guidelines. The USPSTF recommends:
These recommendations apply to people ages 50 - 75 with average risk for colorectal cancer. The USPTF does not recommend routine screening for adults ages 76 - 85 years old who have had negative screenings since age 50. The USPTF does not recommend any screening in people over age 85.
According to the USPTF, there is not yet enough evidence to make recommendations for virtual colonoscopy or stool DNA testing.
Guidelines for Increased-Risk Groups. Screening, particularly with colonoscopy, in increased- and high-risk populations can save lives. The most important risk factors are familial adenomatous polyposis (FAP) or hereditary nonpolyposis colorectal cancer (HNPCC), a family history of colorectal cancer or personal history of colorectal cancer, polyps, or chronic inflammatory bowel disease. People with these risk factors should be screened before age 50 and may need more frequent screenings. [For specific screening recommendations for patients with Crohnâ ' s disease or ulcerative colitis, see In-Depth Reports #103: Crohnâ ' s disease and #69: Ulcerative colitis.]
Colonoscopy. Colonoscopy allows a doctor to view the entire length of the large intestine using a colonoscope, which is inserted into the rectum and snaked through the intestine. A colonoscope is a long, flexible tube that has a video camera one end. The doctor views images from the colonoscope on a display monitor. The test takes about 30 minutes to perform. If polyps are found, the doctor will remove them. The patient is given a sedative prior to the test, which produces a comfortable “twilight” sleep.
In order for the doctor to perform a successful colonoscopy, the colon and rectum must be completely empty. Your doctor will give you complete instructions for how to prepare during the days preceding the tests, and specific foods and liquids to avoid eating and drinking. The day before the test you will be given laxative solution to clean out the colon. Many people find this cleansing more unpleasant than the colonoscopy itself.
Colonoscopy is generally a safe procedure. In very rare cases, complications such as bowel perforation can occur.
Flexible Sigmoidoscopy. Sigmoidoscopy is similar to colonoscopy but only examines the rectum and the lower two feet of the colon. (In contrast, colonoscopy allows the doctor to view the entire colon.) The procedure takes about 10 - 20 minutes, and sedation is optional. Preparation procedures are less demanding than those for colonoscopy.
Double-Contrast Barium Enema (DCBE). The double-contrast barium enema test uses an x-ray to image the entire large intestine. The test takes about 30 - 45 minutes, and sedation is not required. Preparations are similar to those for colonoscopy and sigmoidoscopy. For the test, barium sulfate is inserted into the rectum using a small, flexible tube. The colon is then pumped with air to help the barium spread through the colon. If polyps are detected in the x-ray, your doctor may recommend you have a colonoscopy for further investigation and removal.
Virtual Colonoscopy. Virtual colonoscopy, also called CT colonoscopy, uses a computed tomography (CT) scan to take three-dimensional images of the colon. The test takes only 10 minutes to perform, and does not require sedation. (It does require the same preparations as other procedures to clean out the colon and bowel.) Air is pumped into the rectum through a small flexible tube. The patient is then slid into a CT scanner, which takes rapid images. Recent studies indicate that CT colonoscopy has a high accuracy rate in detecting adenomas and cancers.
Fecal Occult Blood Test (FOBT). A fecal occult blood test is a take-home test that uses stool samples to detect hidden (occult) blood in feces. It may detect small amounts of blood in your stool from polyps or a tumor, even when your stools appear normal. Your doctor will give you a kit with instructions on how to take stool samples and prepare them for the kit. Your doctor will also inform you about what medications and foods need to be avoided in the days prior to the test. The test kit and samples are sent to a laboratory and results usually come back in a few weeks. If blood is found in the stool samples, you will need to have a colonoscopy.
Fecal Immunochemical Test (FIT). The fecal immunochemical test is a newer type of take-home test for hidden (occult) blood. The test is similar to the fecal occult blood test, but patients do not need to follow medication or dietary restrictions. As with the FOBT, a colonoscopy is recommended if blood is found in the stool.
Stool DNA Test. Like the FIT and the FOBT, the stool DNA test is conducted at home and uses fecal samples. Instead of testing for the presence of blood, this test looks for abnormalities in genetic material that come from cancer or polyp cells. These genetic changes are found in genes such as APC, K-ras, and p53. If DNA mutations are found, a colonoscopy is needed. The stool DNA test is new, and is not yet widely available. Some insurance carriers may not cover its testing.
A doctor makes a diagnosis of colorectal cancer based on results of several types of tests. These tests include:
Biopsy. During a colonoscopy, the doctor can remove a tissue sample, which is sent to a laboratory for testing. A biopsy is the only way to definitively diagnose colorectal cancer.
Blood Tests. Blood tests are used to evaluate the red blood cell count and check for anemia. The presence of anemia without any other obvious cause being present will usually require further evaluation of the gastrointestinal tract for a possible cancer. Blood tests are also used to check for specific tumor markers, substances that are released into the blood from cancer cells. Tumor markers include carcinoembryonic antigen (CEA) and CA 19-9. These tests may help your physician follow you for recurrences of colon cancer after treatment. By themselves, they cannot diagnose cancer and are not used as a screening test
Imaging Tests. Various types of imaging tests can help detect the presence of cancer or find out how far the cancer has spread. These tests include ultrasound, chest x-ray, magnetic resonance imaging (MRI) scan, positron emission tomography (PET) scan, and computed tomography (CT) scan.
Botteri E, Iodice S, Raimondi S, Maisonneuve P, Lowenfels AB. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology. 2008 Feb;134(2):388-95. Epub 2007 Nov 4.
Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008 Mar 13;358(11):1160 74.
Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005390.
Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008 Sep 18;359(12):1207-17.
Jonker DJ, O'Callaghan CJ, Karapetis CS, Zalcberg JR, Tu D, Au HJ, et al. Cetuximab for the treatment of colorectal cancer. N Engl J Med. 2007 Nov 15;357(20):2040-8.
Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008 Oct 23;359(17):1757-65.
Kim DH, Pickhardt PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med. 2007 Oct 4;357(14):1403-12.
Kuhry E, Schwenk WF, Gaupset R, Romild U, Bonjer HJ. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003432.
Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med. 2008 Sep 18;359(12):1218-24.
Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008 May-Jun;58(3):130-60. Epub 2008 Mar 5.
Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2533-47.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. V.3.2008
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer. V.3.2008.
U.S. Preventive Services Task Force. Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007 Mar 6;146(5):361-4.
U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008 Nov 4;149(9):627-37. Epub 2008 Oct 6.
Weinberg DS. In the clinic. Colorectal cancer screening. Ann Intern Med. 2008 Feb 5;148(3):ITC2-1-ITC2-16.
Wolpin BM, Mayer RJ. Systemic treatment of colorectal cancer. Gastroenterology. 2008 May;134(5):1296-310.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885